Trials / Recruiting
RecruitingNCT05870969
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
Exploration of A Holistic Management Procedure for Liver Cancer Surveillance in Improving Liver Cancer's Early Diagnosis Efficacy in Chinese Population: Single-Center, Prospective, Observational Real-world Study in EASTERN China
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Ruijin Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the targeted risk population in China.
Conditions
- Carcinoma, Hepatocellular
- Hepatitis C, Chronic
- Hepatitis B, Chronic
- Cirrhosis, Liver
- Non-Alcoholic Fatty Liver Disease
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Liver cancer surveillance every 3 months | Follow up every 3 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam |
| BEHAVIORAL | Liver cancer surveillance every 6 months | Follow up every 6 months for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam |
| BEHAVIORAL | Liver cancer surveillance annually | Follow up annually for liver cancer surveillance, including but not limited to serum AFP test and ultrasound exam |
Timeline
- Start date
- 2023-03-01
- Primary completion
- 2028-03-01
- Completion
- 2028-03-01
- First posted
- 2023-05-23
- Last updated
- 2023-05-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05870969. Inclusion in this directory is not an endorsement.